ADESSO SE (ADN1.DE) Fundamental Analysis & Valuation

FRA:ADN1 • DE000A0Z23Q5

Current stock price

58.3 EUR
-0.2 (-0.34%)
Last:

This ADN1.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ADN1.DE Profitability Analysis

1.1 Basic Checks

  • In the past year ADN1 was profitable.
  • In the past year ADN1 had a positive cash flow from operations.
  • In the past 5 years ADN1 has always been profitable.
  • ADN1 had a positive operating cash flow in each of the past 5 years.
ADN1.DE Yearly Net Income VS EBIT VS OCF VS FCFADN1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.14%, ADN1 is in line with its industry, outperforming 45.71% of the companies in the same industry.
  • ADN1's Return On Equity of 14.06% is fine compared to the rest of the industry. ADN1 outperforms 65.71% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 7.75%, ADN1 is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • ADN1 had an Average Return On Invested Capital over the past 3 years of 3.93%. This is significantly below the industry average of 11.52%.
  • The 3 year average ROIC (3.93%) for ADN1 is below the current ROIC(7.75%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.14%
ROE 14.06%
ROIC 7.75%
ROA(3y)1.19%
ROA(5y)3.29%
ROE(3y)5.14%
ROE(5y)10.94%
ROIC(3y)3.93%
ROIC(5y)4.86%
ADN1.DE Yearly ROA, ROE, ROICADN1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • ADN1 has a worse Profit Margin (1.22%) than 64.29% of its industry peers.
  • In the last couple of years the Profit Margin of ADN1 has declined.
  • Looking at the Operating Margin, with a value of 3.41%, ADN1 is doing worse than 64.29% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ADN1 has declined.
  • ADN1 has a Gross Margin of 85.44%. This is in the better half of the industry: ADN1 outperforms 78.57% of its industry peers.
  • In the last couple of years the Gross Margin of ADN1 has remained more or less at the same level.
Industry RankSector Rank
OM 3.41%
PM (TTM) 1.22%
GM 85.44%
OM growth 3Y-6.08%
OM growth 5Y-12.73%
PM growth 3Y-26.96%
PM growth 5Y-20.92%
GM growth 3Y0.18%
GM growth 5Y-0.58%
ADN1.DE Yearly Profit, Operating, Gross MarginsADN1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ADN1.DE Health Analysis

2.1 Basic Checks

  • ADN1 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, ADN1 has less shares outstanding
  • ADN1 has more shares outstanding than it did 5 years ago.
  • ADN1 has a worse debt/assets ratio than last year.
ADN1.DE Yearly Shares OutstandingADN1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
ADN1.DE Yearly Total Debt VS Total AssetsADN1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • ADN1 has an Altman-Z score of 3.60. This indicates that ADN1 is financially healthy and has little risk of bankruptcy at the moment.
  • ADN1's Altman-Z score of 3.60 is amongst the best of the industry. ADN1 outperforms 81.43% of its industry peers.
  • ADN1 has a debt to FCF ratio of 8.04. This is a slightly negative value and a sign of low solvency as ADN1 would need 8.04 years to pay back of all of its debts.
  • The Debt to FCF ratio of ADN1 (8.04) is worse than 64.29% of its industry peers.
  • A Debt/Equity ratio of 1.57 is on the high side and indicates that ADN1 has dependencies on debt financing.
  • ADN1's Debt to Equity ratio of 1.57 is on the low side compared to the rest of the industry. ADN1 is outperformed by 78.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.57
Debt/FCF 8.04
Altman-Z 3.6
ROIC/WACC1.51
WACC5.13%
ADN1.DE Yearly LT Debt VS Equity VS FCFADN1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that ADN1 should not have too much problems paying its short term obligations.
  • ADN1 has a Current ratio of 1.26. This is comparable to the rest of the industry: ADN1 outperforms 52.86% of its industry peers.
  • A Quick Ratio of 1.26 indicates that ADN1 should not have too much problems paying its short term obligations.
  • ADN1's Quick ratio of 1.26 is in line compared to the rest of the industry. ADN1 outperforms 58.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.26
ADN1.DE Yearly Current Assets VS Current LiabilitesADN1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. ADN1.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 67.67% over the past year.
  • The Earnings Per Share has been decreasing by -3.89% on average over the past years.
  • ADN1 shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.83%.
  • ADN1 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.87% yearly.
EPS 1Y (TTM)67.67%
EPS 3Y-14.06%
EPS 5Y-3.89%
EPS Q2Q%32.01%
Revenue 1Y (TTM)12.83%
Revenue growth 3Y17.64%
Revenue growth 5Y22.87%
Sales Q2Q%125.29%

3.2 Future

  • ADN1 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.90% yearly.
  • ADN1 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.13% yearly.
EPS Next Y59.05%
EPS Next 2Y47.94%
EPS Next 3Y32.87%
EPS Next 5Y28.9%
Revenue Next Year11.43%
Revenue Next 2Y10.78%
Revenue Next 3Y10.56%
Revenue Next 5Y9.13%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ADN1.DE Yearly Revenue VS EstimatesADN1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B 2.5B
ADN1.DE Yearly EPS VS EstimatesADN1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

7

4. ADN1.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • ADN1 is valuated correctly with a Price/Earnings ratio of 14.32.
  • Compared to the rest of the industry, the Price/Earnings ratio of ADN1 indicates a somewhat cheap valuation: ADN1 is cheaper than 71.43% of the companies listed in the same industry.
  • ADN1's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.64.
  • With a Price/Forward Earnings ratio of 11.18, the valuation of ADN1 can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, ADN1 is valued a bit cheaper than 71.43% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.36, ADN1 is valued a bit cheaper.
Industry RankSector Rank
PE 14.32
Fwd PE 11.18
ADN1.DE Price Earnings VS Forward Price EarningsADN1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ADN1 indicates a rather cheap valuation: ADN1 is cheaper than 85.71% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, ADN1 is valued a bit cheaper than 70.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.82
EV/EBITDA 4.28
ADN1.DE Per share dataADN1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ADN1's earnings are expected to grow with 32.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y47.94%
EPS Next 3Y32.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ADN1.DE Dividend Analysis

5.1 Amount

  • ADN1 has a Yearly Dividend Yield of 1.34%.
  • The stock price of ADN1 dropped by -28.29% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • ADN1's Dividend Yield is comparable with the industry average which is at 2.77.
  • Compared to the average S&P500 Dividend Yield of 1.80, ADN1 is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.34%

5.2 History

  • The dividend of ADN1 is nicely growing with an annual growth rate of 10.98%!
Dividend Growth(5Y)10.98%
Div Incr Years1
Div Non Decr Years7
ADN1.DE Yearly Dividends per shareADN1.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • 19.02% of the earnings are spent on dividend by ADN1. This is a low number and sustainable payout ratio.
  • ADN1's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP19.02%
EPS Next 2Y47.94%
EPS Next 3Y32.87%
ADN1.DE Yearly Income VS Free CF VS DividendADN1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
ADN1.DE Dividend Payout.ADN1.DE Dividend Payout, showing the Payout Ratio.ADN1.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ADN1.DE Fundamentals: All Metrics, Ratios and Statistics

ADESSO SE

FRA:ADN1 (4/30/2026, 7:00:00 PM)

58.3

-0.2 (-0.34%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Industry Strength15.54
Industry Growth45.33
Earnings (Last)03-31
Earnings (Next)05-11
Inst Owners19.56%
Inst Owner ChangeN/A
Ins Owners50.29%
Ins Owner ChangeN/A
Market Cap380.70M
Revenue(TTM)2.19B
Net Income(TTM)26.67M
Analysts83.33
Price Target112.03 (92.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.34%
Yearly Dividend0.79
Dividend Growth(5Y)10.98%
DP19.02%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.83%
PT rev (3m)-14.08%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.51%
EPS NY rev (3m)-3.77%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)1.92%
Valuation
Industry RankSector Rank
PE 14.32
Fwd PE 11.18
P/S 0.17
P/FCF 8.82
P/OCF 4.45
P/B 2.01
P/tB 14.47
EV/EBITDA 4.28
EPS(TTM)4.07
EY6.98%
EPS(NY)5.21
Fwd EY8.94%
FCF(TTM)6.61
FCFY11.33%
OCF(TTM)13.1
OCFY22.47%
SpS335.95
BVpS29.05
TBVpS4.03
PEG (NY)0.24
PEG (5Y)N/A
Graham Number51.578 (-11.53%)
Profitability
Industry RankSector Rank
ROA 3.14%
ROE 14.06%
ROCE 14.37%
ROIC 7.75%
ROICexc 9.35%
ROICexgc 15.05%
OM 3.41%
PM (TTM) 1.22%
GM 85.44%
FCFM 1.97%
ROA(3y)1.19%
ROA(5y)3.29%
ROE(3y)5.14%
ROE(5y)10.94%
ROIC(3y)3.93%
ROIC(5y)4.86%
ROICexc(3y)4.85%
ROICexc(5y)6.34%
ROICexgc(3y)7.73%
ROICexgc(5y)10.11%
ROCE(3y)7.28%
ROCE(5y)9.01%
ROICexgc growth 3Y-3.69%
ROICexgc growth 5Y-13.49%
ROICexc growth 3Y-1.87%
ROICexc growth 5Y-10.76%
OM growth 3Y-6.08%
OM growth 5Y-12.73%
PM growth 3Y-26.96%
PM growth 5Y-20.92%
GM growth 3Y0.18%
GM growth 5Y-0.58%
F-Score7
Asset Turnover2.59
Health
Industry RankSector Rank
Debt/Equity 1.57
Debt/FCF 8.04
Debt/EBITDA 2.02
Cap/Depr 58.09%
Cap/Sales 1.93%
Interest Coverage 6.36
Cash Conversion 57.86%
Profit Quality 161.81%
Current Ratio 1.26
Quick Ratio 1.26
Altman-Z 3.6
F-Score7
WACC5.13%
ROIC/WACC1.51
Cap/Depr(3y)53.58%
Cap/Depr(5y)53.05%
Cap/Sales(3y)2.72%
Cap/Sales(5y)2.71%
Profit Quality(3y)855.55%
Profit Quality(5y)534.25%
High Growth Momentum
Growth
EPS 1Y (TTM)67.67%
EPS 3Y-14.06%
EPS 5Y-3.89%
EPS Q2Q%32.01%
EPS Next Y59.05%
EPS Next 2Y47.94%
EPS Next 3Y32.87%
EPS Next 5Y28.9%
Revenue 1Y (TTM)12.83%
Revenue growth 3Y17.64%
Revenue growth 5Y22.87%
Sales Q2Q%125.29%
Revenue Next Year11.43%
Revenue Next 2Y10.78%
Revenue Next 3Y10.56%
Revenue Next 5Y9.13%
EBIT growth 1Y30.75%
EBIT growth 3Y10.49%
EBIT growth 5Y7.24%
EBIT Next Year207.93%
EBIT Next 3Y55.24%
EBIT Next 5Y33.1%
FCF growth 1Y-47%
FCF growth 3Y52.7%
FCF growth 5Y-4.44%
OCF growth 1Y-22.61%
OCF growth 3Y33.36%
OCF growth 5Y5.66%

ADESSO SE / ADN1.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ADESSO SE (ADN1.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ADN1.DE.


Can you provide the valuation status for ADESSO SE?

ChartMill assigns a valuation rating of 7 / 10 to ADESSO SE (ADN1.DE). This can be considered as Undervalued.


How profitable is ADESSO SE (ADN1.DE) stock?

ADESSO SE (ADN1.DE) has a profitability rating of 4 / 10.


What is the financial health of ADESSO SE (ADN1.DE) stock?

The financial health rating of ADESSO SE (ADN1.DE) is 4 / 10.


Can you provide the dividend sustainability for ADN1 stock?

The dividend rating of ADESSO SE (ADN1.DE) is 5 / 10 and the dividend payout ratio is 19.02%.